Rajesh Kumar, Seetha Harilal, Abdullah G. Al-Sehemi, Githa Elizabeth Mathew, Simone Carradori* and Bijo Mathew* Pages 2852 - 2886 ( 35 )
COVID-19, a type of infection that emerged in Wuhan, has become a pandemic affecting people worldwide and is rapidly spreading and evolving. Day by day, the confirmed cases and deaths are increasing many folds. SARS-CoV-2 is a novel virus; therefore, limited data are available to curb the disease. Epidemiological approaches, such as isolation, quarantine, social distancing, lockdown, and curfew, are being employed to halt the spread of the disease. Individual and joint efforts all over the world are producing a wealth of data and information which are expected to produce therapeutic strategies against COVID-19. Current research focuses on the utilization of antiviral drugs, repurposing strategies, vaccine development, as well as basic to advanced research about the organism and the infection. The review focuses on its life cycle, targets, and possible therapeutic strategies, which can lead to further research and development of COVID-19 therapy.
Antiviral drugs, ACE2, COVID-19, MERS-CoV, Drug repurposing, SARS-CoV-2, coronavirus, SARS-CoV, Vaccines.
Department of Pharmacy, Kerala University of Health Sciences, Thrissur, Kerala, Department of Pharmacy, Kerala University of Health Sciences, Thrissur, Kerala, Research center for Advanced Materials Science, King Khalid University, 61413 Abha, Department of Pharmacology, Grace College of Pharmacy, Palakkad, Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, via dei Vestini 31, 66100 Chieti, Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi-682 041